A 14-protein plasma signature predicts lung cancer risk over 5 years ahead, enhancing prevention strategies post-CANTOS, despite high Treat NNT. Insightful! PMID:42242224, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00522-2 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
https://www.cell.com/cell/fulltext/S0092-8674(26)00522-2No description availablewww.cell.com